The Translational Mixer
by Andy Marshall
Latest episode
Episode 12: CHDI's Robert Pacifici on new treatments for…
Episode 12: CHDI's Robert Pacifici on new treatments for…
About this podcast
Two lapsed Nature editors, Andy Marshall and Juan-Carlos Lopez, have a conversation and a cocktail with experts in translational research and biomedicine
Episodes
- Episode 12: CHDI's Robert Pacifici on new treatments for Huntington's toasted with a Boulevardier · 59 min · Season 2 Episode 3Send us Fan Mail Andy and JC get the lowdown from Robert Pacifici, CSO of CHDI Foundation, on the latest in Huntington's treatments from the recent 20th CHDI Therapeutics…
- Episode 11: William Pao on the hunt for life-changing drugs and a refreshing Hugo spritz · 54 min · Season 2 Episode 2Send us Fan Mail William Pao, CEO of Revelio Therapeutics, and former Chief Development Officer for Pfizer/Head of Roche pRED, sits down with JC and Andy to talk about his new…
- Episode 10: Sebastian Giwa blazing a trail in organ storage/transplantation ...and a flaming Sambuca · 54 min · Season 2 Episode 10Send us Fan Mail Sebastian Giwa, co-founder of the Organ Preservation Alliance and the Biostasis Research Institute and serial entrepreneur, talks to JC and Andy about the…
- Episode 9: Charles Fracchia on cyberattacks in biology...and downloading an Aperol Spritz · 55 minSend us Fan Mail Andy and JC explore the murky world of cyberthreats to biopharma and biomanufacturing with Charles Fracchia, CEO of a Boston startup Black Mesa, currently in…
- Episode 8: Andrew Lo on fixing business models in biotech and a sparkling Mio sake! · 56 min · Season 1 Episode 8Send us Fan Mail https://bit.ly/3YxRltJ. Andrew Lo, Charles E. & Susan T. Harris Professor of Finance and director of the Laboratory for Financial Engineering at the MIT Sloan…
- Episode 7: Anne Wyllie, COVID-19, the NBA and spit diagnostics washed down with a G&T! · 58 min · Season 1 Episode 7Send us Fan Mail Anne Wyllie, principal investigator at the Yale School of Public Health and pioneer of the Saliva Direct initiative, talks to JC and Andy about the potential of…
- Episode 6: Veronique Kiermer on open science and a White Negroni · 51 min · Season 1 Episode 6Send us Fan Mail Veronique Kiermer, Chief Scientific Officer and Executive Editor at the Public Library of Science, talks about the myriad ways in which open science is changing…
- Episode 5: Nathan Price on scientific wellness and a Mojito · 50 min · Season 1 Episode 5Send us Fan Mail Nathan Price, currently on leave from the Institute for Systems Biology in Seattle and Chief Scientific Officer at Thorne HealthTech, talks to JC and Andy about…
- Episode 4: Dan Kaufman on off-the-shelf cell therapy and Manhattans · 44 minSend us Fan Mail UCSD's Dan Kaufman, an innovator in the field of induced pluripotent cell (iPSC)-derived natural killer cell therapies, talks to Andy and JC about the latest in…
- Episode 3: Kiran Musunuru, gene and base editors hit the clinic and a Bloody Mary mix · 50 min · Season 1 Episode 3Send us Fan Mail UPenn's Kiran Musunuru, a human geneticist and practicing cardiologist who has pioneered the translation of gene- and base-editing approaches, talks to JC and…
- Episode 2: Eric Topol, multimodal AI models in medicine, and a glass of Merlot · 42 min · Season 1 Episode 2Send us Fan Mail Scripps' Eric Topol is a visionary in the application of artificial intelligence to medicine. He has a wide-ranging conversation with JC and Andy about : 02:52…
- Episode 1: Pete Kirkpatrick, mRNA therapeutics and Espresso Martinis · 50 min · Season 1 Episode 1Send us Fan Mail Pete Kirkpatrick, Chief Editor of Nature Reviews Drug Discovery, gives Andy and JC the lowdown on a Nature Conference on RNA therapeutics and what innovations he…
